AXS Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
AXS Investments's LLY Position: Q2 2026 in Review
AXS Investments reduced its Eli Lilly (LLY) stake by 7.8% in Q2 2026, selling an estimated $11.2K and leaving 130 shares worth $156K. The position accounts for 0.04% of the portfolio, ranked #124.
AXS Investments first reported a position in LLY in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.6M in Q2 2024. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- AXS Investments held 130 shares of Eli Lilly worth $156K as of Q2 2026.
- AXS Investments sold 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
- Eli Lilly made up 0.04% of AXS Investments's portfolio in Q2 2026, its #124 holding.
- AXS Investments first reported a position in Eli Lilly in Q1 2021 and has held it in 20 quarters since.
- AXS Investments's Eli Lilly position peaked at $1.6M in Q2 2024.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.